Cargando…

Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer

PURPOSE: Gemcitabine, cisplatin, and S‐1 chemotherapy was superior to gemcitabine and cisplatin chemotherapy for progression‐free survival and overall survival for unresectable and recurrent biliary tract cancer in a randomized phase III trial (KHBO1401). This study aimed to evaluate the outcome of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nakamura, Ikuo, Hatano, Etsuro, Baba, Hideo, Kamei, Keiko, Wada, Hiroshi, Shimizu, Junzo, Kanai, Masashi, Yoshimura, Kenichi, Nagano, Hiroaki, Ioka, Tatsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623972/ https://www.ncbi.nlm.nih.gov/pubmed/37927929 http://dx.doi.org/10.1002/ags3.12713

Ejemplares similares

Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401‐ MITSUBA)
por: Ioka, Tatsuya, et al.
Publicado: (2022)

Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study
por: Shindo, Yoshitaro, et al.
Publicado: (2023)

Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101)
por: Fujiwara, Yutaka, et al.
Publicado: (2015)

The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato‐Biliary Oncology Group
por: Matsukuma, Satoshi, et al.
Publicado: (2020)

Current progress in perioperative chemotherapy for biliary tract cancer
por: Ioka, Tatsuya, et al.
Publicado: (2023)

Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
por: Toyoda, Masanori, et al.
Publicado: (2014)

Conversion surgery for initially unresectable extrahepatic biliary tract cancer
por: Oh, Moon Young, et al.
Publicado: (2021)

Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report
por: Matsubara, Tokuhiro, et al.
Publicado: (2016)

A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
por: Takahara, Naminatsu, et al.
Publicado: (2022)

Recent progress in the treatment for unresectable biliary tract cancer
por: Endo, Itaru
Publicado: (2023)

Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas
por: Tsuyuguchi, Toshio, et al.
Publicado: (2008)

Unresectable Malignant Biliary Obstruction: Treatment by Self-Expandable Biliary Endoprostheses
por: Glättli, Andreas, et al.
Publicado: (1993)

Does radiotherapy still have a role in unresected biliary tract cancer?
por: Pollom, Erqi L., et al.
Publicado: (2016)

Current Clinical Practice of Precision Medicine Using Comprehensive Genomic Profiling Tests in Biliary Tract Cancer in Japan
por: Kanai, Masashi
Publicado: (2022)

Endoscopic Ultrasound-Guided Biliary Drainage for Unresectable Hilar Malignant Biliary Obstruction
por: Nakai, Yousuke, et al.
Publicado: (2019)

Emerging Systemic Therapies in Advanced Unresectable Biliary Tract Cancer: Review and Canadian Perspective †
por: Tam, Vincent C., et al.
Publicado: (2022)

Endoscopic deployment of multiple (≥ 3) metal stents for unresectable malignant hilar biliary strictures
por: Koshitani, Tatsuya, et al.
Publicado: (2019)

Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results
por: Ueno, Makoto, et al.
Publicado: (2020)

Essential updates to the surgical treatment of biliary tract cancer
por: Matsukuma, Satoshi, et al.
Publicado: (2019)

Recent advances regarding endoscopic biliary drainage for unresectable malignant hilar biliary obstruction
por: Kato, Hironari, et al.
Publicado: (2021)

The usefulness of preoperative bile cultures for hepatectomy with biliary reconstruction
por: Makino, Kenta, et al.
Publicado: (2022)

Clinical Features and Outcomes of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2023)

Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head‐and‐neck cancer
por: Doki, Yuichiro, et al.
Publicado: (2022)

Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients
por: Sakai, Yuji, et al.
Publicado: (2018)

Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)
por: Maruki, Yuta, et al.
Publicado: (2020)

Changing Trends in Biliary Stenting for Unresectable Malignant Perihilar Obstructions
por: Kamani, Lubna, et al.
Publicado: (2020)

Preoperative biliary drainage for biliary tract and ampullary carcinomas
por: Nagino, Masato, et al.
Publicado: (2008)

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma
por: Yanagimoto, Hiroaki, et al.
Publicado: (2020)

BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
por: Nakashima, Shinsuke, et al.
Publicado: (2015)

Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib: Three case reports
por: Tomonari, Tetsu, et al.
Publicado: (2020)

How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective
por: Imai, Katsunori, et al.
Publicado: (2019)

Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
por: Ikeda, Masafumi, et al.
Publicado: (2017)

Optimal endoscopic drainage strategy for unresectable malignant hilar biliary obstruction
por: Naitoh, Itaru, et al.
Publicado: (2023)

New 14-mm diameter Niti-S biliary uncovered metal stent for unresectable distal biliary malignant obstruction
por: Kikuyama, Masataka, et al.
Publicado: (2018)

High Response Rate and Prolonged Survival of Unresectable Biliary Tract Cancer Treated With a New Combination Therapy Consisting of Intraarterial Chemotherapy Plus Radiotherapy
por: Goto, Takuma, et al.
Publicado: (2020)

Radiotherapy With Hydrogen Peroxide-Soaked Gauze for Unresectable Breast Cancer
por: Oike, Takahiro, et al.
Publicado: (2021)

Newly Developed Fully Covered Metal Stent for Unresectable Malignant Biliary Stricture
por: Ito, Kei, et al.
Publicado: (2010)

A Bayesian Network Meta-Analysis Comparing Biliary Stent Types’ Outcome and Complications in Unresectable Malignant Biliary Obstructions
por: Aryanti, Citra, et al.
Publicado: (2023)

Endoscopic Transpapillary Gallbladder Drainage for Recurrent Cholecystitis after Covered Self-expandable Metal Stent Placement for Unresectable Malignant Biliary Obstruction
por: Maruta, Akinori, et al.
Publicado: (2022)

Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
por: Kim, Mi-Jung, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_0vmu55p67d3d0nt0af4hl4rgj0